Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2010 by Samsung Medical Center.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Korean Cancer Study Group
Information provided by:
Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT00561119
First received: November 18, 2007
Last updated: November 8, 2010
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
No publications provided by Samsung Medical Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):